Number of COVID-19 therapeutics in pipeline worldwide Feb. 2021, by R&D stage
As of February 2021, there were around 476 COVID-19 therapeutics worldwide in pre-clinical trial development phase, while 77 therapeutics were in Phase IV. This statistic illustrates the number of COVID-19 therapeutics in the development pipeline worldwide as of February 2021, by R&D stage.